How to Buy Aerovate Therapeutics Stock

Aerovate Therapeutics Inc

Aerovate Therapeutics, Inc. , a clinical-stage biopharmaceutical company, focuses on the development of drugs that enhance the lives of patients with rare cardiopulmonary diseases in the United States.

Aerovate Therapeutics stock last closed at $24.51, up 0.49% from the previous day, and has increased 164.4% in one year. It has overperformed other stocks in the Biotechnology industry by 1.76 percentage points. Aerovate Therapeutics stock is currently +194.24% from its 52-week low of $8.33, and -20.4% from its 52-week high of $30.79.

There are currently 24.61M shares of AVTE outstanding. The market cap of AVTE is $603.07M. In the last 24 hours, 53,559 AVTE shares were traded.

How to Buy Aerovate Therapeutics Stock

Wondering how to invest in Aerovate Therapeutics stock? Here's how.
  1. Figure out where to buy Aerovate Therapeutics stock: You need to pick a stock brokerage, but don't worry - we've sifted through dozens of stock brokerages and apps to help you decide where to buy Aerovate Therapeutics stock.
  2. Create a brokerage account: Sign up for 0% commission trading with the highest-rated brokerage we've found.
  3. Put funds into your brokerage account: Pick your method of payment and add your details.
  4. Analyze Aerovate Therapeutics stock: The Aerovate Therapeutics ticker symbol is AVTE. Is Aerovate Therapeutics stock a good investment? Should you buy shares of AVTE? How do AVTE's underlying business fundamentals look? Do top analysts think Aerovate Therapeutics is a good buy? Why has AVTE's stock price moved recently? (Hint: Our stock research website can help you understand if AVTE is a good stock to buy).
  5. Execute your AVTE purchase: Decide if you will purchase AVTE shares at the current market price or use a limit order to buy AVTE stock at a specific price.
  6. Get the latest news on your investment in AVTE: Create a watchlist to keep track of your position in Aerovate Therapeutics stock.

Step 1: Figure out where to buy Aerovate Therapeutics stock

You need an online brokerage account in order to access the NASDAQ market and buy AVTE shares.

A brokerage account is an investment account that enables you to buy and sell a variety of investments, such as stocks, bonds, mutual funds, and ETFs.

Our favorite brokerage: eToro

Based on our analysis, eToro is the best brokerage. eToro gives you:

  • You can invest in stocks with zero commissions: Invest without paying trading commissions.
  • Buy fractional shares: Even if you don't have the money to buy a full share, you can still purchase the stock.
  • Access to global financial markets: From Tech to Healthcare, New York to Tokyo — you can fill your portfolio with stocks from the world's top exchanges.
  • Social investing: eToro offers a community of more than 20 million users globally. Talk to, learn from, and copy the unique crypto portfolios of other investors.
  • Security: eToro is a regulated and licensed fintech leader.
  • Buy other financial assets: Such as ETFs and cryptos.

Get $10 towards your purchase of shares by opening an account with eToro now.

Open eToro Account

Step 2: Create a brokerage account

Now that you've chosen your brokerage, you'll need to fill out some personal details so you are able to invest in AVTE today.

How to Create a New Brokerage Account on eToro

  1. Click here to get started.
  2. Enter your personal info to start your new trading account.
  1. Send your application by clicking the "Create Account" button.
Get started with eToro today

Step 3: Put funds into your brokerage account

Now that you've finished signing up on one of the best stock apps, you can securely and quickly fund your account:

Check out this video walkthrough for more details transferring funds into your brokerage account.

Get started with eToro today

Step 4: Analyze Aerovate Therapeutics stock

Once you have decided on the best place to buy Aerovate Therapeutics stock, it's very important to evaluate their stock before you buy, so you actually wrap your head around the risk as well as the upside.

Aerovate Therapeutics stock data

AVTE Price
1w %
1y %
5y %
Fore. Rev. Growth
Fore. Earn. Growth
Market Cap
Next Earnings
Mar 29, 2023
Next Dividend

AVTE Fundamentals

WallStreetZen was created to help everyday investors perform more accurate fundamental analysis quickly.

You can see all of the due diligence checks on AVTE's stock page.

Is AVTE stock properly valued?

You can use many financial metrics, analyses, models, and charts to gauge AVTE's true value.

Using relative valuations metrics:

  • AVTE may be undervalued based on its P/B ratio of 4.33x, relative to Biotechnology industry P/B ratio of 5.11x

You can do additional valuation research on AVTE's stock here.

AVTE Financials at a glance


  • AVTE has cash burn of 37626000. It has enough cash and short-term investments to cover this for at least one year.
  • There are more short-term assets than short-term liabilities on the AVTE balance sheet.
  • AVTE has a low debt to equity ratio of 0.06.
  • There are more short-term assets than long-term liabilities on the AVTE balance sheet.
  • AVTE has $142.58M in cash and short term investments. This is sufficient to cover its annual cash burn of $37.63M.

Is it a good time to buy Aerovate Therapeutics stock, according to Wall Street analysts?

Out of 1 sell side analysts who give recommendations on AVTE, the consensus analyst rating on Aerovate Therapeutics is a Strong Buy

Please keep in mind that analyst ratings are not stock recommendations, nor are they financial advice.

Most Recent AVTE Analyst Ratings

Julian Harrison, a top 14% analyst from BTIG upgrades AVTE to a strong buy rating and announces their AVTE price target of $27.00, on Dec 6, 2022.

You can dive deeper into what analysts are forecasting on the Aerovate Therapeutics stock forecast page.

Metrics for Advanced AVTE Traders

MACD Signal
MACD Histogram
Stochastic %K
Stochastic %D
StochRSI %K
StochRSI %D

What are AVTE insiders up to?

Over the past 12 months, executives and large shareholders at AVTE have bought more shares than they have sold.

Timothy P. Noyes, CHIEF EXECUTIVE OFFICER of AVTE, was the latest AVTE insider to sell. They sold $103,609.75 worth of AVTE stock on Feb 1, 2023.

Get more info about who owns AVTE stock here.

Can I get consistent income from AVTE stock?

No, Aerovate Therapeutics doesn't provide an income stream by paying out dividends.

AVTE Social Trading Data

One of the biggest reasons eToro is our highest-rated brokerage is because of its social trading community.

Click below to find out what other traders have to say.

Step 5: Execute your AVTE purchase

You have two primary order types:

  • Market order: A market order is an order to buy or sell a stock at the best price on the market.
    Market orders are generally fine.
  • Limit order: A limit order enables you to buy or sell a security at a specific price (or better).
    If you want to be certain you're buying or selling at a specific dollar amount, place a limit order.

Click the Open button and your broker will place your order.

If you need more info about buying stocks on eToro, watch the helpful video below:

Open eToro Account

Step 6: Get the latest news on your investment in AVTE

Now that you own some shares in AVTE, you'll want to keep up with your new investment.

Put AVTE on a watchlist to get notified of important updates regarding your AVTE stock.


How to Buy Stock in Aerovate Therapeutics

To reiterate, here are the 6 steps to buy Aerovate Therapeutics stock:

  1. Figure out where to buy Aerovate Therapeutics stock
  2. Create a brokerage account
  3. Put funds into your brokerage account
  4. Analyze Aerovate Therapeutics stock
  5. Execute your AVTE purchase
  6. Get the latest news on your investment in AVTE

If you need a brokerage, eToro is our favorite option.

Get Started with eToro Today

If you would like to keep track of your new investment in Aerovate Therapeutics, click below.

$24.51+0.12 (+0.49%)
Updated Feb 3, 2023
Open eToro Account
$24.51+0.12 (+0.49%)
Updated Feb 3, 2023
Open eToro Account


How much does it cost to buy one Aerovate Therapeutics share?

As of Feb 3, 2023, it costs $24.51 to buy one share of Aerovate Therapeutics stock.

Remember, eToro's fractional share buying allows you to buy partial shares of stocks and ETFs. Even if you only have $10, you can buy 0.408 shares of AVTE.

Get Started with eToro Today

Is now a good time to buy Aerovate Therapeutics stock?

According to 1 Wall Street analysts who monitor Aerovate Therapeutics, their consensus recommendation is to buy Aerovate Therapeutics stock.

What is the best way to buy Aerovate Therapeutics stock?

One way to place an order for Aerovate Therapeutics stock is with a brokerage account.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.